Cholesterol, Amyloid Beta, Fructose, and LPS Influence ROS and ATP Concentrations and the Phagocytic Capacity of HMC3 Human Microglia Cell Line
| Autor: | Muñoz Herrera, Oscar M, Hong, Brian V, Ruiz Mendiola, Ulises, Maezawa, Izumi, Jin, Lee-Way, Lebrilla, Carlito B, Harvey, Danielle J, Zivkovic, Angela M |
|---|---|
| Rok vydání: | 2023 |
| Předmět: |
Lipopolysaccharides
Aging microglia Fructose Neurodegenerative Alzheimer's Disease Cell Line Apolipoproteins E Adenosine Triphosphate Alzheimer Disease Acquired Cognitive Impairment Genetics Humans 2.1 Biological and endogenous factors Aetiology Amyloid beta-Peptides Chemical Physics Neurosciences cholesterol Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD) Alzheimer's disease Brain Disorders Cholesterol Dementia Microglia Other Biological Sciences Reactive Oxygen Species Other Chemical Sciences Alzheimer’s disease |
| Zdroj: | International journal of molecular sciences, vol 24, iss 12 |
| Popis: | Research has found that genes specific to microglia are among the strongest risk factors for Alzheimer's disease (AD) and that microglia are critically involved in the etiology of AD. Thus, microglia are an important therapeutic target for novel approaches to the treatment of AD. High-throughput in vitro models to screen molecules for their effectiveness in reversing the pathogenic, pro-inflammatory microglia phenotype are needed. In this study, we used a multi-stimulant approach to test the usefulness of the human microglia cell 3 (HMC3) cell line, immortalized from a human fetal brain-derived primary microglia culture, in duplicating critical aspects of the dysfunctional microglia phenotype. HMC3 microglia were treated with cholesterol (Chol), amyloid beta oligomers (AβO), lipopolysaccharide (LPS), and fructose individually and in combination. HMC3 microglia demonstrated changes in morphology consistent with activation when treated with the combination of Chol + AβO + fructose + LPS. Multiple treatments increased the cellular content of Chol and cholesteryl esters (CE), but only the combination treatment of Chol + AβO + fructose + LPS increased mitochondrial Chol content. Microglia treated with combinations containing Chol + AβO had lower apolipoprotein E (ApoE) secretion, with the combination of Chol + AβO + fructose + LPS having the strongest effect. Combination treatment with Chol + AβO + fructose + LPS also induced APOE and TNF-α expression, reduced ATP production, increased reactive oxygen species (ROS) concentration, and reduced phagocytosis events. These findings suggest that HMC3 microglia treated with the combination of Chol + AβO + fructose + LPS may be a useful high-throughput screening model amenable to testing on 96-well plates to test potential therapeutics to improve microglial function in the context of AD. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|